Literature DB >> 10099508

Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.

J M Berry1, N Barnabé, K M Coombs, M Butler.   

Abstract

Two strains of reovirus were propagated in Vero cells grown in stationary or microcarriers cultures. Vero cells grown as monolayers on T-flasks or in spinner cultures of Cytodex-1 or Cultispher-G microcarriers could be infected with reovirus serotype 1, strain Lang (T1L), and serotype 3, strain Dearing (T3D). A regime of intermittent low speed stirring at reduced culture volume was critical to ensure viral infection of cells in microcarrier cultures. The virus titre increased by 3 to 4 orders of magnitude over a culture period of 150 h. Titres of the T3D reovirus strain were higher (43%) compared to those of the T1L strain in all cultures. Titres were significantly higher in T-flask and Cytodex-1 microcarrier cultures compared to Cultispher-G cultures with respect to either reovirus type. The viral productivity in the microcarrier cultures was dependent upon the multiplicity of infection (MOI) and the cell/bead ratio at the point of infection. A combination of high MOI (5 pfu/cell) and high cell/bead loading (>400 for Cytodex-1 and >1,000 for Cultispher-G) resulted in a low virus productivity per cell. However, at low MOI (0.5 pfu/cell) the virus productivity per cell was significantly higher at high cell/bead loading in cultures of either microcarrier type. The maximum virus titre (8.5 x 10(9) pfu/mL) was obtained in Cytodex-1 cultures with a low MOI (0.5 pfu/cell) and a cell/bead loading of 1,000. The virus productivity per cell in these cultures was 4,000 pfu/cell. The lower viral yield in the Cultispher-G microcarrier cultures is attributed to a decreased accessibility of the entrapped cells to viral infection. The high viral productivity from the Vero cells in Cytodex-1 cultures suggests that this is a suitable system for the development of a vaccine production system for the Reoviridae viruses. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099508     DOI: 10.1002/(sici)1097-0290(19990105)62:1<12::aid-bit2>3.0.co;2-g

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  8 in total

1.  A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism.

Authors:  Laura S Ooms; Takeshi Kobayashi; Terence S Dermody; James D Chappell
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  A novel shell-structure cell microcarrier (SSCM) for cell transplantation and bone regeneration medicine.

Authors:  Kai Su; Yihong Gong; Chunming Wang; Dong-An Wang
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

3.  The effects of microcarrier culture on recombinant CHO cells under biphasic hypothermic culture conditions.

Authors:  Jong Hyun Nam; Myriam Ermonval; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2009-05-02       Impact factor: 2.058

4.  Enhanced production of human recombinant proteins from CHO cells grown to high densities in macroporous microcarriers.

Authors:  T Tharmalingam; K Sunley; M Spearman; M Butler
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

Review 5.  Viral Eco-Genomic Tools: Development and Implementation for Aquatic Biomonitoring.

Authors:  Gomaa Mostafa-Hedeab; Abdou Kamal Allayeh; Hany Abdelfattah Elhady; Abozer Y Eledrdery; Mobarak Abu Mraheil; Ahmed Mostafa
Journal:  Int J Environ Res Public Health       Date:  2022-06-23       Impact factor: 4.614

6.  Ensuring Viral Safety of Equine Immunoglobulins during Production.

Authors:  V V Mashin; A N Sergeev; N N Martynova; M D Oganov; A A Sergeev; V V Kataeva; N V Zagidullin
Journal:  Pharm Chem J       Date:  2022-05-07       Impact factor: 1.063

7.  A serum-free Vero production platform for a chimeric virus vaccine candidate.

Authors:  Inn H Yuk; Gina B Lin; Hui Ju; Inesse Sifi; Yvonne Lam; Armida Cortez; Danny Liebertz; J Michael Berry; Richard M Schwartz
Journal:  Cytotechnology       Date:  2006-11-16       Impact factor: 2.058

8.  The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody.

Authors:  Ana Rita Costa; Joanne Withers; Maria Elisa Rodrigues; Niaobh McLoughlin; Mariana Henriques; Rosário Oliveira; Pauline M Rudd; Joana Azeredo
Journal:  Springerplus       Date:  2013-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.